Cepheid has introduced the GeneXpert ® 16-Site System at the 106th Annual Meeting of the American Society for Microbiology. The latest addition to Cepheid's GeneXpert ® family of real-time PCR devices ...

Renowned molecular diagnostics provider Cepheid CPHD recently entered into a non-exclusive distribution agreement with Henry Schein Medical, the Medical business of one of the leading healthcare ...

Tuberculosis has high prevalence in India. 26% of the cases of tuberculosis are here in India. There are many people that are affected but most importantly 850,000 people go undetected, or undiagnosed ...

California-based molecular diagnostics provider Cepheid CPHD recently entered into a new strategic agreement with long-term partner, Foundation for Innovative New Diagnostics (FIND), a non-profit ...

SpeeDx to bring first sample-to-answer Mycoplasma genitalium and macrolide resistance test to Europe SYDNEY--(BUSINESS WIRE)--SpeeDx Pty, Ltd. today announced the European launch of ResistancePlus® MG ...

The World Health Organisation (WHO) continues to emphasise the critically important role testing plays in curbing the rampaging spread of the pandemic coronavirus (COVID-19). It describes testing as a ...

The Xpert MTB/XDR test developed by the Foundation for Innovative New Diagnostics (FIND) and Cepheid Inc. quickly indicates whether a patient has a dangerous – and rapidly increasing – strain of ...

On November 4, 2022, the United States, through the United States Agency for International Development (USAID), donated 126 cutting-edge GeneXpert tuberculosis (TB) testing machines worth U.S. $3 ...

The audio version of this article is generated by AI-based technology. Mispronunciations can occur. We are working with our partners to continually review and improve the results. Nunavut's Chief ...

Cepheid has introduced the GeneXpert ® 16-Site System at the 106th Annual Meeting of the American Society for Microbiology. Cepheid claims that, batch processing is no longer the only option, as ...